Genetic testing approaches

Genetic testing approaches

Genetic testing approaches

On this page

The Testing Arsenal - From Karyotypes to NGS

Genetic Testing Resolution: Karyotype to Sequencing

  • Karyotyping: Visualizes entire chromosomes. The foundational tool for detecting large-scale changes.

    • Target: Aneuploidies (e.g., Trisomy 21, Turner syndrome) and large structural rearrangements (e.g., translocations).
  • Fluorescence In Situ Hybridization (FISH): Uses fluorescent probes that bind to specific DNA sequences.

    • Target: Known microdeletions/duplications (e.g., 22q11.2 in DiGeorge, Williams syndrome) and confirming rearrangements.
  • Chromosomal Microarray (CMA): High-resolution genome-wide scan for copy number variations (CNVs).

    • Target: Gains (duplications) and losses (deletions) of DNA segments, smaller than what karyotyping can detect.

First-tier test for non-syndromic developmental delay, intellectual disability, and autism spectrum disorder.

  • Next-Generation Sequencing (NGS): Massively parallel sequencing of millions of DNA fragments at once.
    • Target: From single gene variants to the entire genome. Includes gene panels, whole-exome (WES), and whole-genome (WGS) sequencing.

Clinical Clues - Which Test When?

  • Karyotyping: Suspected aneuploidy (e.g., Down, Turner, Klinefelter syndrome) or balanced translocation (e.g., recurrent miscarriages).
  • FISH (Fluorescence In Situ Hybridization): Known microdeletion/duplication syndromes (e.g., DiGeorge, Williams, Prader-Willi/Angelman).
  • Chromosomal Microarray (CMA): First-tier for non-specific presentations like multiple congenital anomalies, unexplained developmental delay/intellectual disability (DD/ID), or autism spectrum disorder (ASD).
  • Next-Generation Sequencing (NGS):
    • Gene Panel: For genetically heterogeneous disorders where multiple genes cause a similar phenotype (e.g., Noonan syndrome, hearing loss, epilepsy).
    • Whole Exome/Genome Sequencing (WES/WGS): For complex cases, diagnostic odysseys, or when panel testing is negative.

Exam Favourite: Chromosomal Microarray (CMA) is the first-tier investigation for a child with unexplained Global Developmental Delay (GDD), Intellectual Disability (ID), or Autism Spectrum Disorder (ASD).

Genetic Testing Approaches: Method, Coverage, Application

Antenatal Answers - Peeking Before Birth

  • Prenatal Screening (Non-invasive): Assesses risk, not a definitive diagnosis.

    • First Trimester Combined Test (11-14 wks):
      • Double Marker: Free β-hCG + PAPP-A.
      • Nuchal Translucency (NT) Scan.
    • Second Trimester Quadruple Test (15-20 wks):
      • AFP, β-hCG, Unconjugated Estriol (uE3), Inhibin A.
    • Non-Invasive Prenatal Testing (NIPT):
      • Analyzes cell-free fetal DNA (cffDNA) in maternal blood from 10 weeks.
      • High accuracy for common aneuploidies.
  • Prenatal Diagnosis (Invasive): Confirmatory tests.

    • Chorionic Villus Sampling (CVS):
      • Done at 10-13 weeks; allows earlier diagnosis.
    • Amniocentesis:
      • Done at 15-20 weeks; lower risk of fetal loss than CVS.

⭐ CVS provides an earlier diagnosis than amniocentesis, but with a slightly higher risk of miscarriage.

Chorionic Villus Sampling (CVS) Procedure

High‑Yield Points - ⚡ Biggest Takeaways

  • Karyotyping is the primary test for aneuploidy (e.g., Trisomy 21) and large structural rearrangements.
  • FISH provides rapid detection of specific microdeletions and aneuploidies (e.g., 22q11.2).
  • Chromosomal Microarray (CMA) is the first-tier test for unexplained developmental delay & multiple congenital anomalies.
  • Sanger sequencing is the gold standard for confirming single-gene mutations found by other methods.
  • Next-Generation Sequencing (NGS) is best for genetically heterogeneous disorders.
  • MLPA excels at detecting exon-level deletions/duplications (e.g., in DMD).

Practice Questions: Genetic testing approaches

Test your understanding with these related questions

A 39-year-old pregnant woman at 16 weeks gestation recently underwent a quad-screen which revealed elevated beta-hCG, elevated inhibin A, decreased alpha-fetoprotein, and decreased estradiol. An ultrasound was performed which found increased nuchal translucency. Which of the following is recommended for diagnosis?

1 of 5

Flashcards: Genetic testing approaches

1/10

What microdeletion syndrome is associated with supravalvular aortic stenosis and renal artery stenosis?_____

TAP TO REVEAL ANSWER

What microdeletion syndrome is associated with supravalvular aortic stenosis and renal artery stenosis?_____

Williams syndrome

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial